Camille Williams
Radiation Oncology · O Fallon, ILNPI 1649436510
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,237 and has fallen 96.8% since, to $39 in 2024.
Across 129 payments — averaging $21.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$371
- Johnson & Johnson$317
- Amgen$219
- Pharmacyclics LLC, An Abbvie Company$167
- AstraZeneca$157
- Merck$157
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,713100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 17 | $371 |
| Johnson & Johnson(2 entities) | 15 | $317 |
| Amgen | 9 | $219 |
| Pharmacyclics LLC, An Abbvie Company | 7 | $167 |
| AstraZeneca(2 entities) | 8 | $157 |
| Merck | 7 | $157 |
| Incyte Corporation | 10 | $146 |
| Seagen Inc. | 5 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $114 |
| Sanofi | 4 | $106 |
| Stemline Therapeutics Inc. | 4 | $81 |
| Novocure Inc. | 2 | $74 |
| Eisai Inc. | 4 | $72 |
| Bayer | 3 | $61 |
| Blueprint Medicines Corporation | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Genmab U.S., Inc. | 2 | $52 |
| AbbVie | 2 | $40 |
| G1 Therapeutics, Inc. | 2 | $36 |
| Sobi, Inc | 2 | $32 |
| Tactile Systems Technology Inc | 2 | $31 |
| Jazz Pharmaceuticals Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Pfizer | 2 | $26 |
| Coherus Oncology, Inc. | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Servier Pharmaceuticals LLC | 1 | $19 |
| Morphosys, US Inc. | 1 | $18 |
| Beigene USA, Inc. | 1 | $18 |
| EMD Serono, Inc. | 1 | $18 |
| Tersera Therapeutics LLC | 1 | $17 |
| ADC Therapeutics America, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $13 |
| Agios Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$2,713 in reported general payments places this provider in the 80th percentile of 242 radiation oncology providers in Illinois.
Other radiation oncology in O Fallon
- Jacob WittO Fallon$10K
- Ramji RajendranElk Grove Village$207K
- Brian BaumannSpringfield$204K
- Tamer RefaatFreeport$151K
- Parthiv MehtaGlenview$149K
- Sean PitrodaChicago$103K
- Aditya JulooriChicago$73K
- Steven ChmuraChicago$59K
- Marc PosnerLake Forest$55K
- William SmallChicago$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.